Who owns CALIDI BIOTHERAPEUTICS INC?
- CUSIP Number: 320703408
Tip: Access positions for across all investors
Analyze quarterly positions in Calidi Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Calidi Biotherapeutics stock
Who bought or sold CALIDI BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| HighTower Advisors | 85k | $129k | 100% | Sep 2025 |
|
| Vanguard Group | 35k | $53k | 100% | Sep 2025 |
|
| Geode Capital Management | 30k | $45k | 100% | Sep 2025 |
|
| Belpointe Asset Management | 21k | $32k | 100% | Sep 2025 |
|
| Warberg Asset Management | 19k | $28k | 100% | Sep 2025 |
|
| Rs Crum | 15k | $23k | 100% | Sep 2025 |
|
| UBS Group | 2.6k | $3.9k | 100% | Sep 2025 |
|
| Highbridge Capital Management | 1.0k | $1.6k | 100% | Sep 2025 |
|
| Finepoint Capital | 1.0k | $1.6k | 100% | Sep 2025 |
|
| Apollo Management Holdings | 1.0k | $1.6k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 417.00 | $1.0k | 100% | Sep 2025 |
|
| Barrett & Company | 292.00 | $443.986000 | 100% | Sep 2025 |
|
| Advisor Group Holdings | 147.00 | $227.997000 | 100% | Sep 2025 |
|
| FMR | 125.00 | $190.000000 | 100% | Sep 2025 |
|
| Tradewinds Capital Management | 101.00 | $154.004800 | 100% | Sep 2025 |
|
| Reyes Financial Architecture | 100.00 | $152.000000 | 100% | Sep 2025 |
|
| SBI Securities | 46.00 | $69.998200 | 100% | Sep 2025 |
|
| CVA Family Office | 42.00 | $63.999600 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 9.00 | $14.000400 | 100% | Sep 2025 |
|
| Evermay Wealth Management | 1.00 | $2.000000 | 100% | Sep 2025 |
|